Drug Shortage Report for ACT NABILONE

Last updated on 2020-03-12 History
Report ID 101740
Drug Identification Number 02393581
Brand name ACT NABILONE
Common or Proper name NABILONE 0.5MG CAPS
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) NABILONE
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 50
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-12-18
Estimated end date
Actual end date 2020-03-11
Shortage status Resolved
Updated date 2020-03-12
Company comments Item is to be discontinued, and transitioned to the TEVA DIN
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-03-12 French Compare
v4 2020-03-12 English Compare
v3 2019-12-19 French Compare
v2 2019-12-19 French Compare
v1 2019-12-19 English Compare